High-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — High-risk cirrhosis patients awaiting liver transplant (LT) most benefit from potential living donors, according to a study published online Sept. 2 in Aging.Fakhar Ali Qazi Arisar, M.B.B.S., from the Unive…
Learn MoreSerum Ammonia, Hospital Mortality Linked in ICU Cirrhosis Patients
THURSDAY, Aug. 3, 2023 (HealthDay News) — For patients with cirrhosis in the intensive care unit (ICU), there is an association between early serum ammonia and hospital mortality, according to a study published online July 20 in Alimentary Pharmacolo…
Learn MoreRacial Disparities Seen Among Hospitalized Patients With Decompensated Cirrhosis
WEDNESDAY, July 26, 2023 (HealthDay News) — Among individuals hospitalized with decompensated cirrhosis, racial and ethnic disparities in the use of complex life-saving procedures and mortality persist, according to a study published online July 20 i…
Learn MoreCirrhosis of the Liver: Causes, Symptoms & Treatment
TUESDAY, June 20, 2023 (HealthDay News) — Cirrhosis of the liver poses a significant health challenge worldwide. With no known cure, it requires comprehensive management to slow liver damage, alleviate symptoms and prevent potential complications.Cir…
Learn MoreIs a Liver Dialysis Device on the Horizon?
FRIDAY, June 2, 2023 (HealthDay News) — A new liver dialysis device might soon be able to save patients on the edge of death from liver failure, early clinical trial results show.The DIALIVE device safely improved organ function and alleviated sympto…
Learn MoreModified Child-Turcotte-Pugh Score Performs Well in Decompensated Cirrhosis
FRIDAY, May 5, 2023 (HealthDay News) — A modified Child-Turcotte-Pugh (aCTP) score based on plasma ammonia (Amm) replacing hepatic encephalopathy (HE) improves discrimination and calibration of transplant-free survival in patients with decompensated …
Learn MoreChatGPT Provides Some Helpful Responses for Liver Diseases
FRIDAY, April 28, 2023 (HealthDay News) — ChatGPT provides easy-to-understand information about basic knowledge, lifestyle, and treatments for cirrhosis and liver cancer, according to a study published online March 21 in Clinical and Molecular Hepato…
Learn MoreUrsodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
MONDAY, April 10, 2023 (HealthDay News) — Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with cirrhosis, according to a study publ…
Learn MoreModel Developed for Predicting Disease Progression in Hep B Liver Cirrhosis
THURSDAY, April 6, 2023 (HealthDay News) — For patients with hepatitis B virus (HBV) liver cirrhosis-acute decompensation (LC-AD), a model combining computed tomography (CT) quantified extracellular liver volume (ECVIC-liver) and chronic liver failur…
Learn MoreBreakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis
TUESDAY, March 7, 2023 (HealthDay News) — Full vaccination cuts the risk for all-cause mortality for breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among chronic liver disease (CLD) patients with cirrhosis by two-…
Learn More